Trials / Not Yet Recruiting
Not Yet RecruitingNCT06847607
A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Bing Han · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of ipecopam in the treatment of refractory/relapsed AIHA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iptacopan | Iptacopan |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2025-10-30
- Completion
- 2026-06-30
- First posted
- 2025-02-26
- Last updated
- 2025-02-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06847607. Inclusion in this directory is not an endorsement.